focus -WSS

focus

author：hotspot 2025-08-19 15:01:50 - browse：128

There’s a specter haunting Wall Street.

It started in biotech, where companies making drugs for the obesity-related liver disease NASH saw their valuations crash on the assumption that GLP-1 weight loss treatments would cut them out of the market. Then the Ozempic panic came for dialysis firms, whose stocks fell about 20% in a single day on the news that Novo Nordisk’s medicine had delayed the progression of kidney disease in a study enrolling people with type 2 diabetes.

Now analysts from every sector are cranking out research notes on the disparate, dramatic, and often debatable implications of GLP-1 drugs’ growing popularity, said Jared Holz, a health care specialist at Mizuho Securities. Buy Bumble, sell McDonald’s. Short Pepsi, go long Louis Vuitton. Put your money in sectors that cater to a svelte and sated brand of consumer, and get out of the ones that rely on excess and compulsion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Boston hospital trains restaurant workers on naloxone for overdoses

WSS

Galapagos to make CAR

Trump cancels press conference intended to dispute Georgia election interference charges

Trump cancels press conference intended to dispute Georgia election interference charges

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Cancer drug shortages' outsize impact on ovarian cancer patients

As Maui death toll rises, number of missing remains unclear

explore

focus

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Listen: Racing for gene therapy & a pioneering approval

Trump demands the U.S. pay no more for drugs than other countries … again

WuXi Biologics execs register to lobby as Congress comes for the company

Medical records are filled with copy

ActiGraph execs on goal of drug approvals with digital endpoints

Heart attack and stroke risk calculators need revising

Eye stem cell transplant could help restore vision in injured people

State Dept. review finds Biden bears some blame for Afghanistan failures

Obesity drug from Roche shows promise in early study

hotspot

STAT series 'Denied by AI' wins major journalism prizes

New details revealed about Purdue's marketing of OxyContin

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

WuXi Biologics beefs up its lobbying operation

Hottest summer in 2,000 years puts focus on extreme heat, health

entertainment

focus

Wikipedia

knowledge